Drug interactions
Linagliptin-metformin + Topiramate
Severity: Moderate
Linagliptin-metformin and Topiramate: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Topiramate can cause hyperchloremic non-anion gap metabolic acidosis by lowering serum bicarbonate. This may complicate metformin therapy and make lactic acidosis harder to recognize or more likely. Topiramate may also modestly increase metformin exposure.
What this interaction means in plain words
Linagliptin-metformin and Topiramate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Linagliptin-metformin belongs to Endocrine; Topiramate belongs to Central Nervous System.
Why it happens
Carbonic anhydrase inhibition by topiramate reduces bicarbonate, producing metabolic acidosis that adds to metformin-associated acidosis risk.
What to do
Monitor serum bicarbonate and acid-base status, and review metformin if persistent acidosis develops.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin-metformin and Topiramate, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Topiramate
Frequently asked questions
Can I take Linagliptin-metformin with Topiramate?
MediHelp rates the interaction as moderate. Linagliptin-metformin and Topiramate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Topiramate can cause hyperchloremic non-anion gap metabolic acidosis by lowering serum bicarbonate. This may complicate metformin therapy and make lactic acidosis harder to recognize or more likely. Topiramate may also modestly increase metformin exposure.
How serious is the interaction between Linagliptin-metformin and Topiramate?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum bicarbonate and acid-base status, and review metformin if persistent acidosis develops.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
